Loading…

A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers

Key Points The blood–central nervous system (CNS) barriers are tight and protect the brain parenchyma from insults, including those of infectious origin. This barrier function is due to the presence of tight junctions between the endothelial cells of the brain. The formation of these junctions is th...

Full description

Saved in:
Bibliographic Details
Published in:Nature reviews. Microbiology 2017-03, Vol.15 (3), p.149-159
Main Authors: Coureuil, Mathieu, Lécuyer, Hervé, Bourdoulous, Sandrine, Nassif, Xavier
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3
cites cdi_FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3
container_end_page 159
container_issue 3
container_start_page 149
container_title Nature reviews. Microbiology
container_volume 15
creator Coureuil, Mathieu
Lécuyer, Hervé
Bourdoulous, Sandrine
Nassif, Xavier
description Key Points The blood–central nervous system (CNS) barriers are tight and protect the brain parenchyma from insults, including those of infectious origin. This barrier function is due to the presence of tight junctions between the endothelial cells of the brain. The formation of these junctions is the consequence of interactions inside the neurovascular unit. There are two blood–CNS barriers that can potentially be circumvented by bacterial pathogens: the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB). The BCSFB corresponds to the choroid plexuses and the microvessels of the leptomeninges. Bacteria can invade the meninges from the bloodstream through the choroid plexuses or directly through the microvessels of the leptomeninges and/or the brain parenchyma. In the case of crossing from parenchyma vessels, bacteria are drained to the subarachnoid space through the glymphatic pathway. Regardless of the site of crossing, meningeal invasion requires the crossing of two cellular barriers: an endothelial monolayer (in the choroid plexus or in the brain parenchyma and/or leptomeninges) followed by an epithelial monolayer (the choroid plexus ependyma, or the leptomeningeal monolayer of the pia mater or of a subarachnoid trabecula). A limited number of blood-borne bacteria can cross the blood–CNS barriers and cause meningitis. The extracellular pathogens that are involved are usually Neisseria meningitidis , Streptococcus pneumoniae or, in newborns, group B Streptococcus and Escherichia coli K1. Regardless of the mechanisms that are used to invade the meninges from the bloodstream, the level of bacteraemia plays a key part in meningeal tropism. The extracellular bacteria interact directly with the blood–CNS barriers. N. meningitidis is believed to cross the blood–CNS barriers by interacting with the leptomeninges and/or brain microvessels, and to open intercellular junctions following signals that are induced by the adhesion of bacteria to the endothelial cells. S. pneumoniae invades the meninges following interaction with the brain microvessels and is believed to transcytose through the endothelial cells following interactions with several host cell receptors. E. coli is believed to transcytose through endothelial cells, to have several attributes that enable it to adhere to endothelial cells and to induce signalling events that lead to bacterial invasion. Bacteria have to overcome many obstacles to invade the meninges from the bloodstre
doi_str_mv 10.1038/nrmicro.2016.178
format article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03552935v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A480952343</galeid><sourcerecordid>A480952343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3</originalsourceid><addsrcrecordid>eNqNks1u1DAQx60K1JbCvScUiUs57OKx4zjpbVUBRVqJC5w4WE482bjK2oudbdUb78Ab8iQ4m2UpqEjIB9vj3388X4ScA50D5eUbF9a2CX7OKBRzkOUROQWZ0xkInj85nFlxQp7FeEMpE0KyY3LCSlpRKotT8mWR3fhtcHifWTf4bOgwq4O27jLdo111w2Tv_F1W62bAYHWfbfTQ-RW6mKXfY8zq3nvz49v3nTJxIVgM8Tl52uo-4ov9fkY-v3v76ep6tvz4_sPVYjlrBOXDrAWDqKFltK21lJzl1KTgGi5yA6zKWcIQhamwaHIuS6gQUJpCs4KbWjT8jLye_Ha6V5tg1zrcK6-tul4s1WijXAhWcXELib2Y2E3wX7cYB7W2scG-1w79NiooJStBplr-B1qkOgOHKqGv_kJ3RU1Jj1QlOJNU_KZWukdlXeuHoJvRqVrkqSOC8Zwnav4IlZbB1GzvsLXJ_oeAToJdLwK2hxoAVeOYqP2YqHFM1JTay32823qN5iD4NRcJgAmI6cmtMDxI6F9OfwJzKMh5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1869532705</pqid></control><display><type>article</type><title>A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers</title><source>Nature Publishing Group</source><creator>Coureuil, Mathieu ; Lécuyer, Hervé ; Bourdoulous, Sandrine ; Nassif, Xavier</creator><creatorcontrib>Coureuil, Mathieu ; Lécuyer, Hervé ; Bourdoulous, Sandrine ; Nassif, Xavier</creatorcontrib><description>Key Points The blood–central nervous system (CNS) barriers are tight and protect the brain parenchyma from insults, including those of infectious origin. This barrier function is due to the presence of tight junctions between the endothelial cells of the brain. The formation of these junctions is the consequence of interactions inside the neurovascular unit. There are two blood–CNS barriers that can potentially be circumvented by bacterial pathogens: the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB). The BCSFB corresponds to the choroid plexuses and the microvessels of the leptomeninges. Bacteria can invade the meninges from the bloodstream through the choroid plexuses or directly through the microvessels of the leptomeninges and/or the brain parenchyma. In the case of crossing from parenchyma vessels, bacteria are drained to the subarachnoid space through the glymphatic pathway. Regardless of the site of crossing, meningeal invasion requires the crossing of two cellular barriers: an endothelial monolayer (in the choroid plexus or in the brain parenchyma and/or leptomeninges) followed by an epithelial monolayer (the choroid plexus ependyma, or the leptomeningeal monolayer of the pia mater or of a subarachnoid trabecula). A limited number of blood-borne bacteria can cross the blood–CNS barriers and cause meningitis. The extracellular pathogens that are involved are usually Neisseria meningitidis , Streptococcus pneumoniae or, in newborns, group B Streptococcus and Escherichia coli K1. Regardless of the mechanisms that are used to invade the meninges from the bloodstream, the level of bacteraemia plays a key part in meningeal tropism. The extracellular bacteria interact directly with the blood–CNS barriers. N. meningitidis is believed to cross the blood–CNS barriers by interacting with the leptomeninges and/or brain microvessels, and to open intercellular junctions following signals that are induced by the adhesion of bacteria to the endothelial cells. S. pneumoniae invades the meninges following interaction with the brain microvessels and is believed to transcytose through the endothelial cells following interactions with several host cell receptors. E. coli is believed to transcytose through endothelial cells, to have several attributes that enable it to adhere to endothelial cells and to induce signalling events that lead to bacterial invasion. Bacteria have to overcome many obstacles to invade the meninges from the bloodstream. This Review considers how extracellular pathogens such as Neisseria meningitides and Streptococcus pneumoniae bypass the blood–brain barriers, the understanding of which may lead to improved methods for delivering drugs into the brain. The blood–brain barrier, which is one of the tightest barriers in the body, protects the brain from insults, such as infections. Indeed, only a few of the numerous blood-borne bacteria can cross the blood–brain barrier to cause meningitis. In this Review, we focus on invasive extracellular pathogens, such as Neisseria meningitidis , Streptococcus pneumoniae , group B Streptococcus and Escherichia coli , to review the obstacles that bacteria have to overcome in order to invade the meninges from the bloodstream, and the specific skills they have developed to bypass the blood–brain barrier. The medical importance of understanding how these barriers can be circumvented is underlined by the fact that we need to improve drug delivery into the brain.</description><identifier>ISSN: 1740-1526</identifier><identifier>EISSN: 1740-1534</identifier><identifier>DOI: 10.1038/nrmicro.2016.178</identifier><identifier>PMID: 28090076</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/326/107 ; 631/326/41/1969/1317 ; 631/326/41/2531 ; 692/699/255/1638 ; Bacteria ; Bacterial infections ; Bacteriology ; Blood-brain barrier ; Blood-Brain Barrier - microbiology ; Brain ; Drug Delivery Systems ; E coli ; Escherichia coli ; Escherichia coli - pathogenicity ; Human health and pathology ; Humans ; Infectious Diseases ; Life Sciences ; Medical Microbiology ; Membranes ; Meninges - microbiology ; Meningitis ; Meningitis, Bacterial - microbiology ; Meningitis, Bacterial - pathology ; Microbiology ; Microbiology and Parasitology ; Neisseria meningitidis ; Neisseria meningitidis - pathogenicity ; Nervous system ; Parasitology ; Pathogenic microorganisms ; Pathogens ; Physiological aspects ; review-article ; Risk factors ; Spinal cord ; Streptococcus ; Streptococcus agalactiae - pathogenicity ; Streptococcus infections ; Streptococcus pneumoniae ; Streptococcus pneumoniae - pathogenicity ; Virology</subject><ispartof>Nature reviews. Microbiology, 2017-03, Vol.15 (3), p.149-159</ispartof><rights>Springer Nature Limited 2017</rights><rights>COPYRIGHT 2017 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Mar 2017</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3</citedby><cites>FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3</cites><orcidid>0000-0003-2852-4765 ; 0000-0003-2855-3240 ; 0000-0001-7655-9685</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28090076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03552935$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Coureuil, Mathieu</creatorcontrib><creatorcontrib>Lécuyer, Hervé</creatorcontrib><creatorcontrib>Bourdoulous, Sandrine</creatorcontrib><creatorcontrib>Nassif, Xavier</creatorcontrib><title>A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers</title><title>Nature reviews. Microbiology</title><addtitle>Nat Rev Microbiol</addtitle><addtitle>Nat Rev Microbiol</addtitle><description>Key Points The blood–central nervous system (CNS) barriers are tight and protect the brain parenchyma from insults, including those of infectious origin. This barrier function is due to the presence of tight junctions between the endothelial cells of the brain. The formation of these junctions is the consequence of interactions inside the neurovascular unit. There are two blood–CNS barriers that can potentially be circumvented by bacterial pathogens: the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB). The BCSFB corresponds to the choroid plexuses and the microvessels of the leptomeninges. Bacteria can invade the meninges from the bloodstream through the choroid plexuses or directly through the microvessels of the leptomeninges and/or the brain parenchyma. In the case of crossing from parenchyma vessels, bacteria are drained to the subarachnoid space through the glymphatic pathway. Regardless of the site of crossing, meningeal invasion requires the crossing of two cellular barriers: an endothelial monolayer (in the choroid plexus or in the brain parenchyma and/or leptomeninges) followed by an epithelial monolayer (the choroid plexus ependyma, or the leptomeningeal monolayer of the pia mater or of a subarachnoid trabecula). A limited number of blood-borne bacteria can cross the blood–CNS barriers and cause meningitis. The extracellular pathogens that are involved are usually Neisseria meningitidis , Streptococcus pneumoniae or, in newborns, group B Streptococcus and Escherichia coli K1. Regardless of the mechanisms that are used to invade the meninges from the bloodstream, the level of bacteraemia plays a key part in meningeal tropism. The extracellular bacteria interact directly with the blood–CNS barriers. N. meningitidis is believed to cross the blood–CNS barriers by interacting with the leptomeninges and/or brain microvessels, and to open intercellular junctions following signals that are induced by the adhesion of bacteria to the endothelial cells. S. pneumoniae invades the meninges following interaction with the brain microvessels and is believed to transcytose through the endothelial cells following interactions with several host cell receptors. E. coli is believed to transcytose through endothelial cells, to have several attributes that enable it to adhere to endothelial cells and to induce signalling events that lead to bacterial invasion. Bacteria have to overcome many obstacles to invade the meninges from the bloodstream. This Review considers how extracellular pathogens such as Neisseria meningitides and Streptococcus pneumoniae bypass the blood–brain barriers, the understanding of which may lead to improved methods for delivering drugs into the brain. The blood–brain barrier, which is one of the tightest barriers in the body, protects the brain from insults, such as infections. Indeed, only a few of the numerous blood-borne bacteria can cross the blood–brain barrier to cause meningitis. In this Review, we focus on invasive extracellular pathogens, such as Neisseria meningitidis , Streptococcus pneumoniae , group B Streptococcus and Escherichia coli , to review the obstacles that bacteria have to overcome in order to invade the meninges from the bloodstream, and the specific skills they have developed to bypass the blood–brain barrier. The medical importance of understanding how these barriers can be circumvented is underlined by the fact that we need to improve drug delivery into the brain.</description><subject>631/326/107</subject><subject>631/326/41/1969/1317</subject><subject>631/326/41/2531</subject><subject>692/699/255/1638</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Bacteriology</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - microbiology</subject><subject>Brain</subject><subject>Drug Delivery Systems</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Escherichia coli - pathogenicity</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Membranes</subject><subject>Meninges - microbiology</subject><subject>Meningitis</subject><subject>Meningitis, Bacterial - microbiology</subject><subject>Meningitis, Bacterial - pathology</subject><subject>Microbiology</subject><subject>Microbiology and Parasitology</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis - pathogenicity</subject><subject>Nervous system</subject><subject>Parasitology</subject><subject>Pathogenic microorganisms</subject><subject>Pathogens</subject><subject>Physiological aspects</subject><subject>review-article</subject><subject>Risk factors</subject><subject>Spinal cord</subject><subject>Streptococcus</subject><subject>Streptococcus agalactiae - pathogenicity</subject><subject>Streptococcus infections</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - pathogenicity</subject><subject>Virology</subject><issn>1740-1526</issn><issn>1740-1534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNks1u1DAQx60K1JbCvScUiUs57OKx4zjpbVUBRVqJC5w4WE482bjK2oudbdUb78Ab8iQ4m2UpqEjIB9vj3388X4ScA50D5eUbF9a2CX7OKBRzkOUROQWZ0xkInj85nFlxQp7FeEMpE0KyY3LCSlpRKotT8mWR3fhtcHifWTf4bOgwq4O27jLdo111w2Tv_F1W62bAYHWfbfTQ-RW6mKXfY8zq3nvz49v3nTJxIVgM8Tl52uo-4ov9fkY-v3v76ep6tvz4_sPVYjlrBOXDrAWDqKFltK21lJzl1KTgGi5yA6zKWcIQhamwaHIuS6gQUJpCs4KbWjT8jLye_Ha6V5tg1zrcK6-tul4s1WijXAhWcXELib2Y2E3wX7cYB7W2scG-1w79NiooJStBplr-B1qkOgOHKqGv_kJ3RU1Jj1QlOJNU_KZWukdlXeuHoJvRqVrkqSOC8Zwnav4IlZbB1GzvsLXJ_oeAToJdLwK2hxoAVeOYqP2YqHFM1JTay32823qN5iD4NRcJgAmI6cmtMDxI6F9OfwJzKMh5</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Coureuil, Mathieu</creator><creator>Lécuyer, Hervé</creator><creator>Bourdoulous, Sandrine</creator><creator>Nassif, Xavier</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-2852-4765</orcidid><orcidid>https://orcid.org/0000-0003-2855-3240</orcidid><orcidid>https://orcid.org/0000-0001-7655-9685</orcidid></search><sort><creationdate>20170301</creationdate><title>A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers</title><author>Coureuil, Mathieu ; Lécuyer, Hervé ; Bourdoulous, Sandrine ; Nassif, Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>631/326/107</topic><topic>631/326/41/1969/1317</topic><topic>631/326/41/2531</topic><topic>692/699/255/1638</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Bacteriology</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - microbiology</topic><topic>Brain</topic><topic>Drug Delivery Systems</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Escherichia coli - pathogenicity</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Membranes</topic><topic>Meninges - microbiology</topic><topic>Meningitis</topic><topic>Meningitis, Bacterial - microbiology</topic><topic>Meningitis, Bacterial - pathology</topic><topic>Microbiology</topic><topic>Microbiology and Parasitology</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis - pathogenicity</topic><topic>Nervous system</topic><topic>Parasitology</topic><topic>Pathogenic microorganisms</topic><topic>Pathogens</topic><topic>Physiological aspects</topic><topic>review-article</topic><topic>Risk factors</topic><topic>Spinal cord</topic><topic>Streptococcus</topic><topic>Streptococcus agalactiae - pathogenicity</topic><topic>Streptococcus infections</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - pathogenicity</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coureuil, Mathieu</creatorcontrib><creatorcontrib>Lécuyer, Hervé</creatorcontrib><creatorcontrib>Bourdoulous, Sandrine</creatorcontrib><creatorcontrib>Nassif, Xavier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Nature reviews. Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coureuil, Mathieu</au><au>Lécuyer, Hervé</au><au>Bourdoulous, Sandrine</au><au>Nassif, Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers</atitle><jtitle>Nature reviews. Microbiology</jtitle><stitle>Nat Rev Microbiol</stitle><addtitle>Nat Rev Microbiol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>15</volume><issue>3</issue><spage>149</spage><epage>159</epage><pages>149-159</pages><issn>1740-1526</issn><eissn>1740-1534</eissn><abstract>Key Points The blood–central nervous system (CNS) barriers are tight and protect the brain parenchyma from insults, including those of infectious origin. This barrier function is due to the presence of tight junctions between the endothelial cells of the brain. The formation of these junctions is the consequence of interactions inside the neurovascular unit. There are two blood–CNS barriers that can potentially be circumvented by bacterial pathogens: the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB). The BCSFB corresponds to the choroid plexuses and the microvessels of the leptomeninges. Bacteria can invade the meninges from the bloodstream through the choroid plexuses or directly through the microvessels of the leptomeninges and/or the brain parenchyma. In the case of crossing from parenchyma vessels, bacteria are drained to the subarachnoid space through the glymphatic pathway. Regardless of the site of crossing, meningeal invasion requires the crossing of two cellular barriers: an endothelial monolayer (in the choroid plexus or in the brain parenchyma and/or leptomeninges) followed by an epithelial monolayer (the choroid plexus ependyma, or the leptomeningeal monolayer of the pia mater or of a subarachnoid trabecula). A limited number of blood-borne bacteria can cross the blood–CNS barriers and cause meningitis. The extracellular pathogens that are involved are usually Neisseria meningitidis , Streptococcus pneumoniae or, in newborns, group B Streptococcus and Escherichia coli K1. Regardless of the mechanisms that are used to invade the meninges from the bloodstream, the level of bacteraemia plays a key part in meningeal tropism. The extracellular bacteria interact directly with the blood–CNS barriers. N. meningitidis is believed to cross the blood–CNS barriers by interacting with the leptomeninges and/or brain microvessels, and to open intercellular junctions following signals that are induced by the adhesion of bacteria to the endothelial cells. S. pneumoniae invades the meninges following interaction with the brain microvessels and is believed to transcytose through the endothelial cells following interactions with several host cell receptors. E. coli is believed to transcytose through endothelial cells, to have several attributes that enable it to adhere to endothelial cells and to induce signalling events that lead to bacterial invasion. Bacteria have to overcome many obstacles to invade the meninges from the bloodstream. This Review considers how extracellular pathogens such as Neisseria meningitides and Streptococcus pneumoniae bypass the blood–brain barriers, the understanding of which may lead to improved methods for delivering drugs into the brain. The blood–brain barrier, which is one of the tightest barriers in the body, protects the brain from insults, such as infections. Indeed, only a few of the numerous blood-borne bacteria can cross the blood–brain barrier to cause meningitis. In this Review, we focus on invasive extracellular pathogens, such as Neisseria meningitidis , Streptococcus pneumoniae , group B Streptococcus and Escherichia coli , to review the obstacles that bacteria have to overcome in order to invade the meninges from the bloodstream, and the specific skills they have developed to bypass the blood–brain barrier. The medical importance of understanding how these barriers can be circumvented is underlined by the fact that we need to improve drug delivery into the brain.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28090076</pmid><doi>10.1038/nrmicro.2016.178</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-2852-4765</orcidid><orcidid>https://orcid.org/0000-0003-2855-3240</orcidid><orcidid>https://orcid.org/0000-0001-7655-9685</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1740-1526
ispartof Nature reviews. Microbiology, 2017-03, Vol.15 (3), p.149-159
issn 1740-1526
1740-1534
language eng
recordid cdi_hal_primary_oai_HAL_hal_03552935v1
source Nature Publishing Group
subjects 631/326/107
631/326/41/1969/1317
631/326/41/2531
692/699/255/1638
Bacteria
Bacterial infections
Bacteriology
Blood-brain barrier
Blood-Brain Barrier - microbiology
Brain
Drug Delivery Systems
E coli
Escherichia coli
Escherichia coli - pathogenicity
Human health and pathology
Humans
Infectious Diseases
Life Sciences
Medical Microbiology
Membranes
Meninges - microbiology
Meningitis
Meningitis, Bacterial - microbiology
Meningitis, Bacterial - pathology
Microbiology
Microbiology and Parasitology
Neisseria meningitidis
Neisseria meningitidis - pathogenicity
Nervous system
Parasitology
Pathogenic microorganisms
Pathogens
Physiological aspects
review-article
Risk factors
Spinal cord
Streptococcus
Streptococcus agalactiae - pathogenicity
Streptococcus infections
Streptococcus pneumoniae
Streptococcus pneumoniae - pathogenicity
Virology
title A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20journey%20into%20the%20brain:%20insight%20into%20how%20bacterial%20pathogens%20cross%20blood%E2%80%93brain%20barriers&rft.jtitle=Nature%20reviews.%20Microbiology&rft.au=Coureuil,%20Mathieu&rft.date=2017-03-01&rft.volume=15&rft.issue=3&rft.spage=149&rft.epage=159&rft.pages=149-159&rft.issn=1740-1526&rft.eissn=1740-1534&rft_id=info:doi/10.1038/nrmicro.2016.178&rft_dat=%3Cgale_hal_p%3EA480952343%3C/gale_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c503t-f1deea1f20fba773240d007c354d12942c50ee5d9e6c437819e1e7d6a263db5c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1869532705&rft_id=info:pmid/28090076&rft_galeid=A480952343&rfr_iscdi=true